Home > Healthcare > Healthcare IT > Telehealth > Tele-epilepsy Market

Tele-epilepsy Market Trends

Report ID: GMI11022
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Tele-epilepsy Market Trends

The expanding elderly population, which is more susceptible to epilepsy, coupled with the overall rise in epilepsy cases, is expected to propel the growth of the market as demand for remote healthcare solutions and management increases.

For instance, according to the World Health Organization (WHO) in 2023, approximately 50 million people worldwide are affected by epilepsy, with a significant portion being elderly individuals. This global prevalence underscores the need for continuous monitoring and management solutions, highlighting the importance of advanced tele-epilepsy technologies for effective care and intervention.
Additionally, advances in telehealth technologies, such as remote electroencephalogram (EEG) monitoring and mobile health apps, are increasingly vital for managing epilepsy. These innovations are fueling market expansion and improving patient outcomes.

These advancements promise to enhance diagnostic accuracy and personalize treatment approaches, driving demand for innovative tele-epilepsy solutions.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The tele-epilepsy industry size was valued at USD 408.1 million in 2023 and will witness 15.9% CAGR from 2024 to 2032 driven by the increasing prevalence of epilepsy and the rising demand for remote management solutions.

The software component segment in the market is anticipated to grow at 16.2% CAGR through 2032 attributed to its vital role in facilitating remote monitoring and epilepsy management, providing stakeholders with essential tools for data collection and patient engagement.

U.S. tele-epilepsy industry size is anticipated to reach USD 795.5 million by 2032 fueled by the high prevalence of epilepsy, which creates substantial demand for advanced management solutions.

Bioserenity SAS, Ceribell, Inc., CortiCare, Inc., Epitel, Inc., Empatica Inc., MedaSync , Medtronic plc, NeuroPace, Inc., and Ovation Healthcare